When you dispense diethylstilbestrol to a patient you must:
a. Inform the patient that the drug is used in estrogen replacement therapy and in
the palliative treatment of breast and prostate cancer.
b. Tell the patient to take the medication until it is gone.
Tell the patient that the drug has been known to cause atrophic vaginitis in
women who are of childbearing age.
d. Provide the patient with a patient package insert (PPI).
The diaphragm method of birth control involves the use of:
a. A mechanical device placed within the uterus.
b. A spermicide in conjunction with a mechanical block inserted in the vagina.
A condom used to cover the penis In order that ejaculated sperm cannot enter
d. A dome-shaped rubber device that is placed over the opening of the vagina.
Which of the following statements best describes a mechanism of action
associated with some oral contraceptive agents?
a. Some oral contraceptives make vaginal secretions (mucous) watery and
noncellular in order to hamper the movement of the sperm.
b. Some oral contraceptives increase progesterone levels that inhibit ovulation by
feedback action on the hypothalamus and subsequent suppression of the
follicle-stimulating hormone and lutinizing hormone.
Some oral contraceptives increase progesterone levels prior to ovulation,
which inhibit the implantation of the ovum within the uterus.
d. Some oral contraceptives block the action of the follicle-stimulating hormone
by depressing the action of the cilia of the fallopian tube.